Content-Type:
Sponsored By An organization or individual has paid to be connected to this work but did not approve or review it.
The Sino-EU PerMed project, launched in January 2020, is a bi-regional consortium of six partners from governmental, funding and research organisations to promote personalised medicine cooperation between Europe and China.
The project was set up as part of a concerted larger effort by the European Commission to increase international collaboration to promote personalised medicine and was devised to engage China in the International Consortium on Personalised Medicine [ICPerMed] – an EU Member States driven initiative and advance the implementation of the Strategic Research and Innovation Agenda on personalised medicine.
This Euractiv report explains the purpose of the project, what it set out to achieve, and the expected outcomes.